21:28:59 EST Tue 17 Nov 2026
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
CHARLOTTE'S WEB HOLDINGS, INC.
Symbol CWEB
Shares Issued 271,291,529
Close 2026-11-17 C$ 0.25
Market Cap C$ 67,822,882
Recent Sedar+ Documents

ORIGINAL: Charlotte's Web Backs Bipartisan Plan for a Responsible Federal Hemp Framework That Protects Consumers and Preserves Access

Company urges Congress to replace Section 781's sweeping hemp restrictions with sound, enforceable standards that protect children, eliminate synthetic and restricted intoxicating products such as delta-8 THC, and preserve access to therapeutic hemp products

2026-11-17 19:35 ET - News Release

Louisville, Colorado--(Newsfile Corp. - November 17, 2026) - Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF) today announced its strong support for the Hemp Guardrails Act, with bipartisan legislation introduced today by U.S. Senators Tim Sheehy (R-MT) and Amy Klobuchar (D-MN) that would replace the 0.4 milligram per-container limit in Section 781 of the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 and establish a federal regulatory framework that protects consumers while preserving access to responsibly manufactured hemp products.

Section 781, set to take effect December 11, 2026, imposes a 0.4 milligram total-THC-per-container limit that fails to distinguish naturally occurring, non-intoxicating trace THC in full-spectrum hemp from synthetic and intoxicating THC products. Charlotte's Web has consistently challenged an approach that fails to distinguish non-intoxicating full-spectrum products from synthetic and intoxicating THC products.

"This is the moment to get hemp policy right once and for all," said Bill Morachnick, Chief Executive Officer of Charlotte's Web. "We thank Senators Sheehy and Klobuchar for their leadership and for putting forward a responsible path that protects consumers without taking away access. We were here when the category began, and for more than a decade we've worked to show what responsible hemp should look like: investing in research, rigorous testing, quality and safety standards, and transparency at every step. Senators Sheehy and Klobuchar's approach recognizes that protecting consumers and protecting access are not competing goals. They are the same responsibility."

The proposed framework would establish strict federal guardrails, including:

  • Replacing Section 781's 0.4 mg-per-container restriction with a regulated federal pathway for hemp-derived cannabinoid products;
  • Establishing a 21+ age requirement, child-resistant packaging, appropriate warnings and strong protections against marketing to minors;
  • Restricting specified intoxicating cannabinoids, including Delta-8 THC, Delta-10 THC, HHC and THC-O-acetate, and prohibiting interstate sale of smokable hemp flower and pre-rolls;
  • Continuing to exclude synthetic cannabinoids that cannot be naturally produced by the hemp plant;
  • Establishing FDA oversight and enforcement, including manufacturing standards, third-party testing, facility registration, recalls and transparent labeling with access to certificates of analysis;
  • Creating regulatory pathways for qualifying hemp-derived cannabinoid products and dietary supplements under the Federal Food, Drug, and Cosmetic Act;
  • Increasing the hemp cultivation threshold from 0.3% to 1% total THC, including THCA, on a dry-weight basis, while requiring covered interstate products to use U.S.-grown hemp and domestic processing, finishing, packaging and labeling;
  • Preserving HHS authority to include qualifying cannabinoid dietary supplements in the CMS Beneficiary Engagement Incentive and as specified Medicare Advantage supplemental benefits; and
  • Preserving state authority to enact stricter protections, while protecting interstate passage of products that comply with the federal framework.

Veterans, seniors, and families managing complex health challenges are among those who rely on full-spectrum hemp products as a part of their health routines.

"Consumers should not pay the price for an industry fight over market share," said Morachnick. "Senators Sheehy and Klobuchar's proposal gives Congress a path forward: set the highest standards for safety, quality, and accountability, preserve responsible access, and hold all of us to them. Charlotte's Web is ready."

About Charlotte's Web Holdings, Inc.
Charlotte's Web Holdings, Inc., a Certified B Corporation headquartered in Louisville, Colorado, is a botanical wellness innovation company and a market leader in hemp extract wellness that includes Charlotte's Web whole-plant full-spectrum CBD (cannabidiol) extracts as well as broad-spectrum CBD and other naturally occurring cannabinoid isolates, terpenes, flavonoids, and other beneficial compounds. Charlotte's Web product categories include CBD oil tinctures (liquid products), CBD gummies (sleep, calming, exercise recovery, immunity), CBN gummies, functional mushroom gummies, CBD capsules, CBD topical creams, and lotions. Through its substantially vertically integrated business model, Charlotte's Web maintains stringent control over product quality and consistency with analytical testing from soil to shelf for quality assurance. Charlotte's Web products are distributed to retailers and healthcare practitioners throughout the U.S.A. and are available online through the Company's website at www.charlottesweb.com.

Forward-Looking Information

Certain information provided herein constitutes forward-looking statements or information (collectively, "forward-looking statements") within the meaning of applicable securities laws. Forward-looking statements are typically identified by words such as "may," "will," "should," "could," "would," "anticipate," "expect," "project," "estimate," "forecast," "plan," "intend," "target," "believe" and similar words suggesting future outcomes or statements regarding an outlook. Forward-looking statements are not guarantees of future performance and readers are cautioned against placing undue reliance on forward-looking statements.

Specifically, this press release contains forward-looking statements relating to, but not limited to: whether the Hemp Guardrails Act or comparable legislation is enacted, and the timing of any enactment, including whether it occurs before December 11, 2026 or as part of government funding legislation; the final scope and terms of any such legislation, including its THC thresholds, restricted cannabinoids, age requirement, domestic sourcing requirements, interstate transport protections and preservation of state and federal agency authority; the timing and content of regulations the Food and Drug Administration and the Department of Health and Human Services may adopt under any such legislation; the scope and effect of the restrictions under Section 781 scheduled to take effect on December 11, 2026; the eligibility of the Company's products under any resulting federal framework; and the Company's expectations regarding the development of a durable federal regulatory framework for hemp-derived products. These statements are based on assumptions the Company believes are reasonable, including that the Hemp Guardrails Act or comparable legislation is enacted on substantially the terms described herein and that the Company's products would qualify under the resulting framework. Risks and uncertainties include, among other things: failure of Congress to enact the Hemp Guardrails Act or any other federal hemp framework before December 11, 2026 or at all, or enactment on terms less favorable than anticipated; amendments to the legislation during the legislative process; delays in, or unfavorable outcomes of, federal rulemaking, including the absence of agency guidance on restricted cannabinoids and container limits; additional or more restrictive state laws; costs of complying with new testing, packaging, labeling and registration requirements; the effect on the Company's sales if the Section 781 restrictions take effect as scheduled; and the risk factors discussed under the heading "Risk Factors" in the Company's most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings available at www.sec.gov and www.sedarplus.ca.

Any forward-looking statement in this press release is based only on information currently available to the Company and speaks only as of the date on which it is made. Except as required by applicable law, the Company assumes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. All forward-looking statements, whether written or oral, attributable to the Company or persons acting on the Company's behalf, are expressly qualified in their entirety by these cautionary statements.

For further information:
Media inquiries: cw@ampublicrelations.com
Shareholder inquiries: ir@charlottesweb.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/324588

© 2026 Canjex Publishing Ltd. All rights reserved.